AIMD · Ainos Inc
United States · RS rating 5 · As of 2026-10-14
| Price | 0.96 USD |
|---|---|
| 1-day change | -11.1% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 6 / 6 / 7 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 13 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -51.2% |
| Sales growth Q/Q | +413.1% |
| Distance from 52-week high | +77.4% |
| Market cap (USD) | $12.9M |